Commonwealth Equity Services LLC lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 55.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 110,529 shares of the company’s stock after purchasing an additional 39,361 shares during the period. Commonwealth Equity Services LLC’s holdings in Cardinal Health were worth $17,349,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Geode Capital Management LLC grew its holdings in Cardinal Health by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 6,389,049 shares of the company’s stock worth $1,069,005,000 after acquiring an additional 205,539 shares during the last quarter. Norges Bank acquired a new position in shares of Cardinal Health during the second quarter worth approximately $584,420,000. Invesco Ltd. grew its stake in shares of Cardinal Health by 7.3% during the second quarter. Invesco Ltd. now owns 3,037,782 shares of the company’s stock valued at $510,347,000 after purchasing an additional 207,750 shares during the last quarter. Legal & General Group Plc grew its stake in shares of Cardinal Health by 2.0% during the second quarter. Legal & General Group Plc now owns 2,349,767 shares of the company’s stock valued at $394,761,000 after purchasing an additional 45,812 shares during the last quarter. Finally, Marshall Wace LLP increased its holdings in shares of Cardinal Health by 19.1% in the second quarter. Marshall Wace LLP now owns 1,930,967 shares of the company’s stock valued at $324,402,000 after purchasing an additional 309,335 shares in the last quarter. 87.17% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several research firms have issued reports on CAH. Argus upped their price objective on Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Evercore ISI upped their price target on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Robert W. Baird set a $232.00 price objective on Cardinal Health in a report on Friday, October 31st. Finally, UBS Group raised their target price on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research note on Friday, October 31st. Fourteen investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $212.60.
Cardinal Health Trading Down 0.7%
Cardinal Health stock opened at $201.06 on Friday. The firm has a market capitalization of $47.77 billion, a P/E ratio of 30.33, a PEG ratio of 1.47 and a beta of 0.65. The business has a 50-day moving average of $204.05 and a 200-day moving average of $173.10. Cardinal Health, Inc. has a 1 year low of $119.25 and a 1 year high of $214.93.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. Cardinal Health’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same period last year, the company posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Stories
- Five stocks we like better than Cardinal Health
- Best $19 you’ll spend this year.
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Wall Street Stockpicker Names #1 Stock of 2026
- Buy this stock tomorrow?
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
